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ABSTRACT
We studied the influence of orchiectomy (GDX) and steroid administration
on the level of the cytosolic androgen receptor in the rat levator ant muscle
and in rat skeletal muscles (tibialis anterior and extensor digito rum
longus). Androgen receptor binding to muscle cytosol was measured using ( 3HJ-
methyltrienolone (R1881) as ligand, 100-fold molar excess unlabeled R1881 to
assess non-specific binding, and 500-fold molar excess of triamcinolone
acetonide to prevent binding to glucocorticoid and progestin receptors. Bound
-nd free ligand were separated by column chromatography with Sephadex C-75.
In levator ant muscles from intact animals (controls), maximum R18E1 binding
(Borax) ueterm-ned by Scatchard analysis was 2.5 fmol/mg protein (K d - 0.68
nM).	 Thirty days _fter GDX, Bmax increased to 500% control with no
significant change in Kd (0.96 nM). Using saturating levels of R1881, Bmax
was increased to 280% control at 12 hours post GDX, 700% at 14 days, 478% at
30 days, and 133% at 44 days with respect to controls. 	 The increase in
receptor binding was blocked by cycloheximi.de.	 Administration of Silastic
capsules containing testosterone propionate (TP) at 30 days post-GDX resulted
in R1881 binding at the control level at 44 days. 	 Surprisingly,
administration of estradiol-170 (E 2 ) at 30 days post-GDX resulted in increased
(480%) R1881 binding. Thus, E 2 may cause induction of the cytosolic androgen
receptor in levator ant muscle from GDX rats; alternatively, the rate of
receptor degradation may be altered. R1881 binding by skeletal muscle cytosol
was increased 139% at 12 h, 212', at day 14, 220% at day 30 and 158% at day 44
with respect to control. Administration of TP at 30 days caused R1881 binding
to return to control by day 44, whereas E 2 was without influence.	 The
differences in response of levator ant and skeletal muscle receptors may
account for the differential effects of sex steroids on these muscle types.
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INTRODUCTION
Androgenic hormones have marked effects on growth (1, 2) and metabolic
activity (3-6) of striated muscle. The mechanism of androgen action on muscle
is probably via a cytosolic androgen receptor, which has recently been
identified in striated muscle (7-11). This receptor has been shown to have
similar physiochemical properties to androgen receptors in prostate gland and
kidney (12, 13).
The properties of the cytosolic androgen receptor might be expected to
influence the sensitivity of muscle to hormone (14). If so, this would reveal
an importan' physiological mechanism for regulation of androgen hormone
7.
action.	 In an attempt to determine the factors that are important to
regulation of the androgen receptor in muscle, we manipulated the horLonal
milieu of rats and measured maximum binding and ligand affinity. The results
to be described reveal a striking effect of gonadectomy and hormone
administration on androgen receptor binding.
Methods
Rats
Adult male Sprague Dawley rats weighing 150-250 g were purchased from
Charles River Breeding Labs., Wilmington, *lass. 	 Orchiectomy (GDR) was
performed via an abdominal incision under ether anesthesia. 	 Two types of
muscle were examined: 1) the levator ani muscle, ; perineal muscle that is
dependent upon androgens for growth and that has a relatively high level of
androgen receptors (10, 15), and 2) the extensor digitorum longus and tibialis
anterior muscles, characteristic fast twitch skeletal muscles.
Chemicals
[ 3H] R1881 ([ 3H]-methyltrienolone) and unlabeled R1881 were purchased
from New England Nuclear. All other chemicals were purchased from the Sigma
Chemical Co. (St. Louis, MO).
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UHoimone Administration
Steroids were administered by subcutaneous implantation of Dow-Corning
Silastic medical grade tubing (outer diameter, 0.125 inches; inner diameter,
0.062 inches) filled with crystalline (17) or dissolved steroid (16).
Estradiol-176 was dissolved in sesame oil (150 yg/mg) and administered in 20
mm lengths. These estradiol-containing Silastic capsules have been shows: to
deliver hormone levels of 15-20 pg/ml over 5 days (19). 	 Crystalline
testosterone propionate was packed into Silastic tubing and implanted in 30 mm
lengths to produce physiologic levels (17). 	 Capsules were changed after 7
days to ensure continuous delivery of hormone. Identical surgical procedures
were performed on cr atrol rats without implantation of capsules.
Protocols
Binding parameters and time-course of receptor changes following castration
Rats were killed at 0, 12 h, 14 d, 30 d and 44 d after castration.
Specific binding parameters (apparent Kd , Bmax) of cytosolic androgen receptor
were determined in levator ani and skeletal m;,scles by Scatchard (18) analysis
using 0.5-10.0 nM [ 3H] R1881 in the 0 and 30 day castrates. Receptor number
was determined by using a saturating concentration of [ 3H] R1881 (8 nM for
levator ani muscle, apparent Kd 0.68 nM, and 5 nM for skeletal muscle) at all
time periods. The saturating concentration is et the plateau of a graph of
bound vs log free ligand concentration, as recommended. by Klotz (19), and
therefore represents a reliable estimate of Bmax. 	 A typical isotherm for
R1881 specific binding in rat levator ani muscle cytosol is given in an
earlier report from this laboratory (10).
Effect of cycloheximide
At the time of castration, rats received an i.p. injection of 50 mg/kg
cycloheximide dissolved in 0.9% NaCl. The animals ware decapitated after 6 h,
and muscles were removed for receptor binding assays.
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Effect of hormone administration
Animals were castrated, and after 30 days they were implanted with
subcutaneous Silastic capsules of either testosterone propionate or estradiol-
176 for an additional 14 days. Controls were killed 44 days after castration.
:4ssa s
Androgen receptor - After rats were decapitated, muscles were dissected,
weighed, placed on ice, and minced with scissors. All subsequent operations
were carried out in the cold room (0-4 0 ). The levator ani muscle was diluted
f
(4:1, w/v) in buffer {Tris (50 mM), EDTA (0.1 mM), dithiothreitol (0.25 MM)
and glycerol (10% v/v), pH 7.4] and homogenized by hand with a Tenbroeck
5
homogenizer (Bellco Glass Co.). Skeletal muscle was frozen and pulverized in
liquid nitrogen using a mortar and pestle. Skeletal muscle powders were
occasionally stored at -80 0C, with no loss of receptor binding capacity. For
receptor assay, the powders were diluted (2:1, w/v) in buffer and were
homogenized ub'.ng a Polytron (Brinkman-Sybron) for 3 x 5 sec bursts at setting
5.
The androgen receptor assay was performed as described previously (10,
11). Triamcinolone acetonide (500-fold molar excess) was included in the
incubation mixture to prevent binding to progestin and glucocorticoid
receptors (20, 21). beparation of bound from free ligand was accomplished by
column (18 x 0.5 cm) chromatography using Sephadex C-75. 	 Ten 0.8 ml
fractions, eluted with homogenization buffer, were collected from each column.
Protein was determined	 by the method	 of Lowry et	 al.	 (22) using
crystalline bovine serum	 albumin as standard. DNA was determined by	 the
method of Burton (23) using calf thymus DNA as standard.
Statistics
Binding data of muscle from 0 and 30 day castrated rats were analyzed
according to Scatchard (18).
	 Equality of slopes was tested by analysis of
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covariance (24). Statistical comparisons were made using t-tests and Tukey's
post test (25).
Results
Binding parameters and time-course of receptor changes following castration
In levator ani muscles from gonadally intact animals (controls), apparent
maximum R1881 binding (Bmax) determined by Scatchard analysis was 2.5 fmol/mg
protein (apparent Kd - 0.68 nM) (Fig. 1).	 Thirty days after GDX, apparent
Bmax increased to 500% control with no significant change in apparent Kd (Fig.
1).
Using saturating levels of [ 3 H] R1881, apparent Bmax (fmols/mg protein)
in levator ani muscle increased to 2802 control at 12 h post gonadectomy, 700%
at 14 days, 478% at 30 days and 133% control at 44 days (Fig. 2). Although
the magnitude of the change was smaller, skeletal muscle showed a similar
trend; R1881 binding was increased 139% at 12 h, 212% at day 14, 220% at day
30 and 158% at day 44 with respect to controls (Fig. 3). Changes in receptor
level were also demonstrated in both muscle types when data were expressed in
terms of fmols/mg DNA (Figs. 2 and 3).
Effect of cycloheximide
[ 3H) R1881 binding in the levator ani muscle increased by 56% (p < 0.01)
6 h after orchiectomy. Simultaneous injection of cycloheximide blocked this
increase in apparent Bmax (Table I).	 Cycloheximide also blocked the acute
increase in receptor binding in skeletal muscle (Table I).
Effect of hormone administration
Administration of estradiol-170 at 30 days post-castration resulted in a
striking increase in [ 3H] R1881 specific binding at day 44 in the levator ani
muscle (Fig. 4).	 An identical result was seen with diethylstilbestrol (not
shown).	 Administration of testosterone propionate was without effect (Fig.
4).	 In contrast, administration of estradiol-176 had no effect on receptor
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binding in skeletal muscle, and testosterone reduced binding (Fig. 5).
Discussion
The present study demonstrates that modification of the levels of sex	 l
steroids can alter the content of androgen receptors of rat striated muscle.
Both the estradiol-0 and testosterone-containing implants we employed have
bee, shown to deliver physiological levels of steroids (16, 17). These data
demonstrate that 1) cytosolic androgen receptor levels increase after
orchiectomy in both levator ani muscle and skeletal muscle; 2) the acute
increase in receptor is blocked by an inhibitor of protein synthesis; and, 3)
administration of estradiol-170 to castrated animals increases receptor
binding it levator ani muscle but not in skeletal muscle.
We	 are in	 agreement	 with	 previous	 experiments	 showing an	 increase	 in
cytosolic androgen receptor in rat skeletal muscle after gonadectomy (8,	 26).
This
	 is	 Di contrast	 to	 the	 result of Michael and Baulieu (9), who reported a
decrease	 in receptor	 level	 in the quadriceps muscles 	 for up to 9 days	 after
castratioi. Our	 data	 further	 demonstrate	 an	 increase	 of receptor	 after
castration that is of greater magnitude in the levator ani muscle than in
skeletal muscle.	 This response is consistent with the exquisite hormone
sensitivity of the levator ani muscle.
The return of cytosolic receptor binding to the control level in the
levator ani muscle in 30 days, but not in skeletal muscle, may be due to
proteolysis involved in the pronounced atrophy of the levator ani muscle after
castration.
To elucidate further the mechanism of the increase in receptor binding,
we injected cycloheximide, an inhibitor of protein synthesis, at the time of
gonadectomy. Gycloheximide was effective in blocking the rise in [3H] R1881
binding in levator ani and skeletal muscles. Therefore, the acute increase in
cytosolic androgen receptor levels may reflect de novo receptor synthesis.
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Contribution of other factors, e.g., 1) increased availability of receptor for
binding with [ 3H] R18F1 by removal of endogenous hormone, 2) movement of
nuclear receptor into the cytosolic pool, or, 3) decreased degradation of
receptor, cannot be excluded. Indeed, Cidlowski and Muldoon (27) showed that
a similar rise of estradiol receptor was partly owing to receptor synthesis
and partly owing to nuclear recycling. That the acute rise in receptor level
following castration may depend on protein synthesis suggests that
testosterone down-regulates its own receptor, although movement into the
nuclear pool cannot be ruled out. This is reinforced by the demonstration
that, in skeletal muscle (Fig. 5), , physiologic amounts of testosterone reduced
the castrate receptor level to the control level in skeletal muscle.
The present result^ are consistent with recent observations from this
laboratory that androgens and estrogens may act synergistically to enhance
glucose 6-phosphate dehydrogenase activity in the levator ani muscle (28).
These data suggest that estradiol can induce cytosolic androgen receptors in
muscle.	 The increased cytosolic receptor cen then interact with androgen,
translocate to the nucleus, and interact with the genome to influence enzyme
activity.	 The data also provide an explanation for the estrogen-mediated
increase in protein deposition in muscle of farm animals (29, 30).
Increases in cytosolic androgen receptor levels after estrogen treatment
have also been shown in dog prostate gland (31) and in the chick oviduct
(32); other examples of receptor regulation have been reviewed (33). Further
studies will be needed to determine whether this effect of estrogen is due to
an interaction with specific estrogen receptors, which have been identified in
striated muscle (34).
a.
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Figure Legends
Figure 1 - Scatchard analysis of the effect of gonadectomy on [3H] R1881
specific binding in rat levator ani muscle. Apparent K d was unaffected by
castsration.
Figure 2 - Time-course of effect of gonadectomy on [ 3111 81881 specific
binding in rat levator ani muscle.	 Data are means f sem of 6.8
determinations. *Significantly different trom control, p < 0.01.
Figure 3 - Time-course of effect of gonadectomy on [ 3H] R1881 specific
binding in rat extensor digitorum longus and tibialis anterior muscles. Data
are means f sem of 6-10 determinations. 	 *Significantly different from
control, p < 0.01.
Figure 4 - Effect of sex steroids on [ 3 H] R1881 specific binding in rat
levator ani muscle following gonadectomy (GDX).	 Thirty days after GDX one
group of rats received Silastic implants of estradiol-179 	 (E 2 ) for an
additional V.- days.	 A second group of GDX rats received Silastic implants
containing testosterone propionate (TP). 	 Data are means f sem of 6-8
determinations. *Significantly different from control, p < 0.01.
Figure 5 - Effect of sex steroids on [ 3H] R1881 specific binding in rat
skeletal muscles following gonadectomy (GDX). Thirty days after GDX one group
of rats received Silastic implants of estradiol-179 (E2 ) for an additional 14
days. A second group of 30-day GDX rats received Silastic implants containing
testosterone propionate (TP). 	 Data are means t sem of 8-10 determinations.
*Significantly different floor control, p < 0.01.
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TABLE I
Effec t. of Cycloheximide on the Castration-Mediated Increase
in r3 H] 81881 Specific Binding in Rat Levxtor Ani Muscle
Levator Ani Muscle 	 Skeletal Muscle
1
Treatment
None
Castration
Castration +
cycloheximide
fmols/mg protein
4.35 + 0.2 (3)
6.62 + 0.8 (3)*
2.72 + 0.5 (4)*
fmols/mg protein
0.83 + 0.09
1.25 + 0.15*
0.95 + 0.06
*Significantly different from control, p < 0.05. Rats
were castrated for 6 hours. Cycloheximide (50 mg/kg)
was injected (i.p.) at the time of castration. Data
are means + sem. The number of determinations is in
parentheses.
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